Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Short stature-pituitary and cerebellar defects-small sella turcica syndrome is characterized by short stature, anterior pituitary hormone deficiency, small sella turcica, and a hypoplastic anterior hypophysis associated with pointed cerebellar tonsils. It has been described in three generations of a large French kindred. Ectopia of the posterior hypophysis was observed in some patients. The syndrome is transmitted as a dominantly inherited trait and is caused by a germline mutation within the LIM-homeobox transcription factor LHX4 gene (1q25).
Features include always present findings: Small sella turcica. 9 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Growth and development | 4 | Short stature, Pituitary dwarfism, Severe postnatal growth retardation |
Hormones | 4 | Pituitary dwarfism, Hypothyroidism, Impaired growth-hormone response to insulin stimulation test |
Bones and joints | 1 | Marked delay in bone age |
LHX4 encodes LIM homeobox 4 (390 aa). May play a critical role in the development of respiratory control mechanisms and in the normal growth and maturation of the lung. Binds preferentially to methylated DNA Highest expression in Testis (5.2 TPM) and Brain Cerebellum (5.0 TPM).
Short stature-pituitary and cerebellar defects-small sella turcica syndrome is associated with mutations in the LHX4 gene on chromosome 1.
The LHX4 protein participates in SLIT2 gene expression is stimulated by ISL1 and Regulation of expression of SLITs and ROBOs pathways.
LHX4 is classified as a druggable target (Transcription Factor category) with score 0.0.
Genetic testing for LHX4 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for short stature-pituitary and cerebellar defects-small sella turcica syndrome has been reported in the published literature.
Phenotype severity distribution: 1 always present feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for short stature-pituitary and cerebellar defects-small sella turcica syndrome.
126 publications have been identified in PubMed for short stature-pituitary and cerebellar defects-small sella turcica syndrome. Research spans Basic Science / Preclinical (43%), Review / Meta-Analysis (33%), and Case Report / Case Series (8%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 54 | 43% |
Research summaries | 42 | 33% |
Patient case studies | 10 | 8% |
Disease patterns and progression | 8 | 6% |
Testing and diagnosis research | 4 | 3% |
Other research | 3 | 2% |
Clinical study results | 3 | 2% |
New treatment approaches | 2 | 2% |
Tabuchi K (2026). [PMID: 41831576](https://pubmed.ncbi.nlm.nih.gov/41831576/). *Mol Cells*. [Review / Meta-Analysis]
Shi Q (2026). [PMID: 42052621](https://pubmed.ncbi.nlm.nih.gov/42052621/). *Front Cell Neurosci*. [Diagnostic / Biomarker]
Hafiz S (2026). [PMID: 32965955](https://pubmed.ncbi.nlm.nih.gov/32965955/). *Unknown Journal*. [Basic Science / Preclinical]
Chen X (2026). [PMID: 41578548](https://pubmed.ncbi.nlm.nih.gov/41578548/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
He R (2026). [PMID: 41165761](https://pubmed.ncbi.nlm.nih.gov/41165761/). *J Clin Invest*. [Basic Science / Preclinical]
Kular S (2026). [PMID: 32119496](https://pubmed.ncbi.nlm.nih.gov/32119496/). *Unknown Journal*. [Case Report / Case Series]
Zhang J (2026). [PMID: 40855003](https://pubmed.ncbi.nlm.nih.gov/40855003/). *Mol Psychiatry*. [Basic Science / Preclinical]
Osório C (2026). [PMID: 41803111](https://pubmed.ncbi.nlm.nih.gov/41803111/). *Nat Commun*. [Basic Science / Preclinical]
Ribeiro AC (2026). [PMID: 40554621](https://pubmed.ncbi.nlm.nih.gov/40554621/). *J Clin Endocrinol Metab*. [Epidemiology / Natural History]
Garg RK (2026). [PMID: 42237532](https://pubmed.ncbi.nlm.nih.gov/42237532/). *Mov Disord Clin Pract*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 8:41 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center